Innovation in the Chest Pain Pathway, how NHS England is Leading the way with Cardiac CT and Artificial Intelligence

Published: 24 March 2022

  • Views:

    Views Icon 30101
  • Likes:

    Heart Icon 7

Overview

According to NICE,  HeartFlow FFRct should be considered as an option for patients with stable, recent-onset chest pain who are offered CCTA. Using HeartFlow FFRct may avoid the need for invasive coronary angiography and revascularisation. 

 

Based on the current evidence and assuming there is access to appropriate CCTA facilities, using HeartFlow FFRct may lead to cost savings of £391 per patient [2021].

https://www.nice.org.uk/guidance/mtg32/ 

 

During this video series, you will learn more about the GIRFT report and its recommendations to understand the role of CT and FFRct as a way to meet demand with capacity and deliver cost savings to the NHS in accordance with the NICE guidance.

 

In the third part, you will hear about the MedTech Funding Mandate and the experience of CCGs in adopting CT and FFRct to streamline the Chest Pain Pathway and reduce costs.

 

Find out more about HeartFlow at www.heartflow.com

This video series is supported by:

Learning Objectives

  • Explore the role of non invasive FFRct analysis
  • Review clinical evidence supporting clinical utility health economics and safety of HeartFlow analysis
  • Insights from high-volume centres in implementing a CT / FFRct pathway
  • Learn More about the GIRFT report and its recommendations
  • Understand the role of CT and FFRct as a way meet demand with capacity and deliver cost savings to the NHS in accordance with the NICE guidance

Target Audience

  • Interventional and general cardiologists
  • Cardiac imaging specialists and radiologists
  • Cardiac Imagers
  • Radiologists
  • Cardiac CT specialists
  • Commissioners
  • NHS providers-clinical teams and corporate teams
  • Integrated Care Boards /Systems
  • AHSN's
  • AHSN technology teams

More from this programme

Part 1

AI Powered CT Based Non Invasive CAD Testing: The Future Is Now

Jonathon Leipsic a Professor of Radiology and Cardiology at the University of British Columbia and Dr Carlos Collet, an Interventional Cardiologist from OLV Ziekenhuis Aalst review and discuss three interesting cases and the role of CTA + FFRct.

Part 2

Innovation in the Chest Pain pathway, how NHS England is leading the way with Cardiac CT and Artificial Intelligence

In this episode leading experts Profs Derek Connolly and Simon Ray, look at insights and recommendations from the GIRFT report that can help streamline the chest pain pathway, reduce costs, provide a faster diagnosis without multiple visits to hospitals and have a real impact on improving the quality of care for patients.

Faculty Biographies

Carlos Collet

Carlos Collet

Dr Carlos Collet practices as interventional cardiologist at OLV-Aalst, Belgium. Dr. Collet has published more than 80 peer review articles and his focus of research is on the integration of cardiac imaging and physiology.

View full profile
Jonathon A Leipsic

Jonathon A Leipsic

Chairman

Jonathon Leipsic is Chairman of the Department of Radiology for Providence Health Care and the Vice Chairman of Research for the UBC Department of Radiology. 

He is Professor of Radiology and Cardiology at the University of British Columbia, and has over 400 peer reviewed manuscripts in press and print and is also the editor of 2 textbooks. 

 

View full profile